{"DataElement":{"publicId":"2950100","version":"1","preferredName":"Finding Present Type","preferredDefinition":"A description of clinical, laboratory or molecular evidence of disease that was present.","longName":"2943226v1.0:2939747v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2943226","version":"1","preferredName":"Finding Present","preferredDefinition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease._Being or existing in a specified place or at the specified time.","longName":"2528734v1.0:2233878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2528734","version":"1","preferredName":"Finding","preferredDefinition":"Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom).","longName":"C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2041574B-49B4-016F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-20","endDate":null,"createdBy":"UMLLOADER_CGOM","dateCreated":"2006-10-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F6B2C3-4629-DCB1-E040-BB89AD4353A4","latestVersionIndicator":"Yes","beginDate":"2009-09-19","endDate":null,"createdBy":"DWARZEL","dateCreated":"2009-09-19","modifiedBy":"KUMMEROA","dateModified":"2018-08-15","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2939747","version":"1","preferredName":"Finding Type","preferredDefinition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease._Type; a subdivision of a particular kind of thing.","longName":"2939747v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Hepatomegaly","valueDescription":"Hepatomegaly","ValueMeaning":{"publicId":"2939748","version":"1","preferredName":"Hepatomegaly","longName":"2939748","preferredDefinition":"Hepatomegaly; abnormal enlargement of the liver.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatomegaly","conceptCode":"C3100","definition":"Abnormal enlargement of the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7350EF78-48C3-5D1F-E040-BB89AD431E2E","latestVersionIndicator":"Yes","beginDate":"2009-09-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-09-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FC2B62E-8B80-FC2A-E040-BB89AD435F5A","beginDate":"2010-09-08","endDate":null,"createdBy":"SORENSENS","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"Splenomegaly","valueDescription":"Splenomegaly","ValueMeaning":{"publicId":"2939749","version":"1","preferredName":"Splenomegaly","longName":"2939749","preferredDefinition":"Splenomegaly; an abnormal enlargement of the spleen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Splenomegaly","conceptCode":"C3384","definition":"Abnormal enlargement of the spleen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7350EF78-48E6-5D1F-E040-BB89AD431E2E","latestVersionIndicator":"Yes","beginDate":"2009-09-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-09-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FC2B62E-8B94-FC2A-E040-BB89AD435F5A","beginDate":"2010-09-08","endDate":null,"createdBy":"SORENSENS","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"Systemic symptoms","valueDescription":"Systemic Symptom","ValueMeaning":{"publicId":"2939750","version":"1","preferredName":"Systemic Symptom","longName":"2939750","preferredDefinition":"(sis-TEM-ik) Affecting the entire body.: An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Systemic","conceptCode":"C13310","definition":"Affecting an entire system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7350EF78-490C-5D1F-E040-BB89AD431E2E","latestVersionIndicator":"Yes","beginDate":"2009-09-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-09-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FC2B62E-8BAA-FC2A-E040-BB89AD435F5A","beginDate":"2010-09-08","endDate":null,"createdBy":"SORENSENS","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A366F43E-377E-9973-E040-BB89AD43108C","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"Warts","valueDescription":"Verrucous Lesion","ValueMeaning":{"publicId":"3235572","version":"1","preferredName":"Verrucous Lesion","longName":"3235572","preferredDefinition":"A raised growth on the surface of the skin or other organ.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Verrucous Lesion","conceptCode":"C5028","definition":"A papillomavirus related epithelial overgrowth. It can be located anywhere on the body though when it involves the perineal region it is generally referred to as condyloma acuminatum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A366F43E-378A-9973-E040-BB89AD43108C","latestVersionIndicator":"Yes","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A366F43E-37A5-9973-E040-BB89AD43108C","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"Veno-occlusive disease","valueDescription":"Veno-Occlusive Disease","ValueMeaning":{"publicId":"2768635","version":"1","preferredName":"Veno-Occlusive Disease","longName":"2768635","preferredDefinition":"Disorder in which veins are partially or completely obstructed or the blood flow through the veins is suboptimal.--2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Veno-Occlusive Disease","conceptCode":"C8301","definition":"Disorder in which veins are partially or completely obstructed or the blood flow through the veins is suboptimal.--2004","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52DDF902-A307-5647-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-07-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A366F43E-37B9-9973-E040-BB89AD43108C","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"Thrombotic thrombocytopenia purpura","valueDescription":"Thrombocytopenic Purpura","ValueMeaning":{"publicId":"2769001","version":"1","preferredName":"Thrombocytopenic Purpura","longName":"2769001","preferredDefinition":"Purpura associated with a reduction in circulating blood platelets which can result from a variety of factors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytopenic Purpura","conceptCode":"C26870","definition":"Purpura associated with a reduction in circulating blood platelets which can result from a variety of factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-993E-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A366F43E-37CD-9973-E040-BB89AD43108C","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"Growth retardation","valueDescription":"Growth Retardation","ValueMeaning":{"publicId":"2944853","version":"1","preferredName":"Growth Retardation","longName":"2944853","preferredDefinition":"Stature that is smaller than normal as expected for age.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Growth Retardation","conceptCode":"C78328","definition":"Stature that is smaller than normal as expected for age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7445E0D3-185A-319E-E040-BB89AD434CDB","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A366F43E-3806-9973-E040-BB89AD43108C","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"Growth hormone deficiency","valueDescription":"Growth Hormone Deficiency","ValueMeaning":{"publicId":"3235574","version":"1","preferredName":"Growth Hormone Deficiency","longName":"3235574","preferredDefinition":"A peptide hormone secreted by the anterior lobe of the pituitary gland and regulates several physiologic processes, including growth and metabolism.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Somatotropin","conceptCode":"C2288","definition":"Somatotropin (217 aa, ~25 kDa) is encoded by the human GH1 gene. This protein is involved in the regulation of many physiologic processes, including the growth of organs and tissues and the metabolism of amino acids and proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A366F43E-3813-9973-E040-BB89AD43108C","latestVersionIndicator":"Yes","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A366F43E-382C-9973-E040-BB89AD43108C","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"Chronic graft versus host disease","valueDescription":"Chronic Graft Versus Host Disease","ValueMeaning":{"publicId":"2769010","version":"1","preferredName":"Chronic Graft Versus Host Disease","longName":"2769010","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9A9A-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"KUMMEROA","dateModified":"2023-10-30","changeDescription":null,"administrativeNotes":"2023.10.30 Alt VM added per ticket request CADSR0003010. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A366F43E-3840-9973-E040-BB89AD43108C","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"Acute graft versus host disease","valueDescription":"Acute Graft Versus Host Disease","ValueMeaning":{"publicId":"2769014","version":"1","preferredName":"Acute Graft Versus Host Disease","longName":"2769014","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9B21-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A366F43E-3854-9973-E040-BB89AD43108C","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"Failure to thrive","valueDescription":"Failure to Thrive","ValueMeaning":{"publicId":"3235575","version":"1","preferredName":"Failure to Thrive","longName":"3235575","preferredDefinition":"A clinical finding indicating less than normal growth in infancy or early childhood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infant Failure to Thrive","conceptCode":"C85038","definition":"A clinical finding indicating less than normal growth in infancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A366F43E-385E-9973-E040-BB89AD43108C","latestVersionIndicator":"Yes","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A366F43E-3877-9973-E040-BB89AD43108C","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"Autoimmune hemolytic anemia","valueDescription":"Autoimmune Hemolytic Anemia","ValueMeaning":{"publicId":"3131205","version":"1","preferredName":"Autoimmune Hemolytic Anemia","longName":"3131205","preferredDefinition":"An acquired anemia caused by destruction of the red blood cells by autoantibodies. Causes include autoimmune disorders, lymphoproliferative disorders, infections and drugs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune Hemolytic Anemia","conceptCode":"C34378","definition":"An acquired anemia caused by destruction of the red blood cells by autoantibodies. Causes include autoimmune disorders, lymphoproliferative disorders, and infections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E463458-E315-7F10-E040-BB89AD433128","latestVersionIndicator":"Yes","beginDate":"2010-08-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A366F43E-388B-9973-E040-BB89AD43108C","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","deletedIndicator":"No"},{"value":"Other hematologic impairment","valueDescription":"Other Hematologic Impairment","ValueMeaning":{"publicId":"3286129","version":"1","preferredName":"Other Hematologic Impairment","longName":"3286129","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Pertaining to or related to the blood and blood-forming organs.: Loss or abnormality of psychological, physiological, or anatomic structure or function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hematologic","conceptCode":"C62780","definition":"Pertaining to or related to the blood and blood-forming organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Impairment","conceptCode":"C21055","definition":"Loss or abnormality of psychological, physiological, or anatomic structure or function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADF31655-2D53-2768-E040-BB89AD430D8E","latestVersionIndicator":"Yes","beginDate":"2011-09-27","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE1AFBC1-CCDD-4A0C-E040-BB89AD434199","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Strabismus / nystagmus","valueDescription":"Strabismus And/Or Nystagmus","ValueMeaning":{"publicId":"3286130","version":"1","preferredName":"Strabismus And/Or Nystagmus","longName":"3286130","preferredDefinition":"Misalignment of the visual axes of the eyes. In comitant strabismus the degree of ocular misalignment does not vary with the direction of gaze. In noncomitant strabismus the degree of misalignment varies depending on direction of gaze or which eye is fixating on the target. (Miller, Walsh & Hoyt's Clinical Neuro-Ophthalmology, 4th ed, p641): Used to indicate that either or both of two items or options: Involuntary movements of the eyeballs. The presence or absence of nystagmus is often used in the diagnosis of a variety of neurological and visual disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Strabismus","conceptCode":"C35040","definition":"Strabismus is the intermittent or constant misalignment of an eye so that its line of vision is not pointed at the same object as the other eye. Strabismus is caused by an imbalance in the extraocular muscles which control the positioning of the eyes. Strabismus is normal in newborns but should resolve by the time the baby is 6 months old. In older children with strabismus, the brain may learn to ignore the input from one eye, and this may lead to amblyopia, a potentially permanent decrease in vision in that eye if not corrected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nystagmus","conceptCode":"C3282","definition":"Involuntary movements of the eyeballs. The presence or absence of nystagmus is often used in the diagnosis of a variety of neurological and visual disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADF31655-2D7A-2768-E040-BB89AD430D8E","latestVersionIndicator":"Yes","beginDate":"2011-09-27","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE1AFBC1-CCE7-4A0C-E040-BB89AD434199","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Skull circumference above 95th percentile","valueDescription":"Skull Circumference Greater Than Integer::5 Percentile","ValueMeaning":{"publicId":"3287772","version":"1","preferredName":"Skull Circumference Greater Than Integer::5 Percentile","longName":"3287772","preferredDefinition":"The skeleton of the head including the bones of the face and the bones enclosing the brain.: The length of the closed curve of a circle; the size of something as given by the distance around it.: A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A number with no fractional part.::5: Any of the 99 numbered points that divide an ordered set of scores into 100 parts each of which contains one-hundredth of the total.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skull","conceptCode":"C12789","definition":"The bones that form the head, made up of the bones of the braincase and face.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Circumference","conceptCode":"C64265","definition":"The length of the closed curve of a circle; the size of something as given by the distance around it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Percentile","conceptCode":"C48919","definition":"Any of the 99 numbered points that divide an ordered set of scores into 100 parts each of which contains one-hundredth of the total.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE1AFBC1-CCF7-4A0C-E040-BB89AD434199","latestVersionIndicator":"Yes","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE1AFBC1-CD10-4A0C-E040-BB89AD434199","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Hypertriglyceridemia","valueDescription":"Hypertriglyceridemia","ValueMeaning":{"publicId":"2946154","version":"1","preferredName":"Hypertriglyceridemia","longName":"2946154","preferredDefinition":"Hypertriglyceridemia; the condition of elevated triglyceride concentration in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertriglyceridemia","conceptCode":"C37971","definition":"A laboratory test result indicating elevated triglyceride concentration in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746BC102-0687-7D5C-E040-BB89AD4332CB","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ADDDD4D5-09F1-A1C9-E040-BB89AD43373A","beginDate":"2011-09-26","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-26","modifiedBy":"ONEDATA","dateModified":"2011-09-26","deletedIndicator":"No"},{"value":"Hypofibrinogenemia","valueDescription":"Hypofibrinogenemia","ValueMeaning":{"publicId":"3285367","version":"1","preferredName":"Hypofibrinogenemia","longName":"3285367","preferredDefinition":"A blood coagulation disorder characterized by low levels of fibrinogen in the blood, resulting in bleeding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypofibrinogenemia","conceptCode":"C98131","definition":"A blood coagulation disorder characterized by low levels of fibrinogen in the blood, resulting in bleeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADDDD4D5-09FD-A1C9-E040-BB89AD43373A","latestVersionIndicator":"Yes","beginDate":"2011-09-26","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ADDDD4D5-0A16-A1C9-E040-BB89AD43373A","beginDate":"2011-09-26","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-26","modifiedBy":"ONEDATA","dateModified":"2011-09-26","deletedIndicator":"No"},{"value":"Aplastic Anemia","valueDescription":"Aplastic Anemia","ValueMeaning":{"publicId":"2593270","version":"1","preferredName":"Aplastic Anemia","longName":"2593270","preferredDefinition":"A condition in which the bone marrow is unable to produce blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aplastic Anemia","conceptCode":"C2870","definition":"Anemia resulting from bone marrow failure (aplastic or hypoplastic bone marrow). The production of erythroblasts and red cells is markedly decreased, and it may be associated with decreased production of granulocytes (granulocytopenia) and platelets (thrombocytopenia) as well. Aplastic anemia may be idiopathic or secondary due to bone marrow damage by toxins, radiation, or immunologic factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2880D74E-659D-0A0D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DB45-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Septicemia","valueDescription":"Septicemia","ValueMeaning":{"publicId":"2946181","version":"1","preferredName":"Septicemia","longName":"2946181","preferredDefinition":"The presence of pathogenic microorganisms in the blood stream causing a rapidly progressing systemic reaction that may lead to shock. Symptoms include fever, chills, tachycardia, and increased respiratory rate. It is a medical emergency that requires urgent medical attention.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Septicemia","conceptCode":"C3364","definition":"The presence of pathogenic microorganisms in the blood stream causing a rapidly progressing systemic reaction that may lead to shock. Symptoms include fever, chills, tachycardia, and increased respiratory rate. It is a medical emergency that requires urgent medical attention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746BFDBA-4A29-B144-E040-BB89AD4341DF","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DB5E-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Osteomyelitis","valueDescription":"Osteomyelitis","ValueMeaning":{"publicId":"2871912","version":"1","preferredName":"Osteomyelitis","longName":"2871912","preferredDefinition":"An acute or chronic inflammation of the bone and its structures due to infection with pyogenic bacteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteomyelitis","conceptCode":"C27577","definition":"An acute or chronic inflammation of the bone and its structures due to infection with pyogenic bacteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6959F7C9-3F79-BC97-E040-BB89AD4308BF","latestVersionIndicator":"Yes","beginDate":"2009-05-07","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DB68-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Nasal congestion","valueDescription":"Nasal Congestion","ValueMeaning":{"publicId":"2945783","version":"1","preferredName":"Nasal Congestion","longName":"2945783","preferredDefinition":"The blockage of the nasal passage due to mucosal edema. It is usually the result of a viral infection or an allergic reaction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasal Congestion","conceptCode":"C78500","definition":"The blockage of the nasal passage due to mucosal edema. It is usually the result of a viral infection or an allergic reaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7458E815-91FC-DD76-E040-BB89AD43104A","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DB72-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Gross motor delay","valueDescription":"Gross Motor Skill Delay","ValueMeaning":{"publicId":"3286131","version":"1","preferredName":"Gross Motor Skill Delay","longName":"3286131","preferredDefinition":"The ability to use large muscle groups for gross body movements.  This developmental skill begins in infancy and early childhood.: Delay; time during which some action is awaited; inactivity resulting in something being put off until a later time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gross Motor Skill","conceptCode":"C88420","definition":"The ability to use large muscle groups for gross body movements. This developmental skill begins in infancy and early childhood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Delay","conceptCode":"C25476","definition":"Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADF31655-2DA0-2768-E040-BB89AD430D8E","latestVersionIndicator":"Yes","beginDate":"2011-09-27","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DB7C-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Hypertelorism","valueDescription":"Hypertelorism","ValueMeaning":{"publicId":"3286136","version":"1","preferredName":"Hypertelorism","longName":"3286136","preferredDefinition":"Abnormal increase in the interorbital distance due to overdevelopment of the lesser wings of the sphenoid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertelorism","conceptCode":"C34715","definition":"A condition in which there is an abnormally increased distance between two organs or bodily parts; most often, this term is referring to an increased distance between the orbits (orbital hypertelorism).","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADF31655-2E7F-2768-E040-BB89AD430D8E","latestVersionIndicator":"Yes","beginDate":"2011-09-27","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DB86-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Height below 5th percentile","valueDescription":"Height Less Than Integer::5 Percentile","ValueMeaning":{"publicId":"3287500","version":"1","preferredName":"Height Less Than Integer::5 Percentile","longName":"3287500","preferredDefinition":"Height; the vertical dimension of extension; distance from the base of something to the top.: A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: A number with no fractional part.::5: Any of the 99 numbered points that divide an ordered set of scores into 100 parts each of which contains one-hundredth of the total.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Height","conceptCode":"C25347","definition":"The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Less Than","conceptCode":"C61585","definition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Percentile","conceptCode":"C48919","definition":"Any of the 99 numbered points that divide an ordered set of scores into 100 parts each of which contains one-hundredth of the total.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE180EC5-DB95-780D-E040-BB89AD432111","latestVersionIndicator":"Yes","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DBAE-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Hearing impairment","valueDescription":"Hearing Impairment","ValueMeaning":{"publicId":"2944866","version":"1","preferredName":"Hearing Impairment","longName":"2944866","preferredDefinition":"Partial or complete loss of the ability to detect or understand sounds resulting from damage to the outer, middle, or inner ear structures. Causes include exposure to loud noise, ear infections, injuries to the ear, genetic, and congenital disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hearing Impairment","conceptCode":"C50576","definition":"Partial or complete loss of the ability to detect or understand sounds resulting from damage to the outer, middle, or inner ear structures. Causes include exposure to loud noise, ear infections, injuries to the ear, genetic, and congenital disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7445E0D3-19BC-319E-E040-BB89AD434CDB","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DBC2-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Frontal bossing / prominent forehead","valueDescription":"Frontal Bossing","ValueMeaning":{"publicId":"3287501","version":"1","preferredName":"Frontal Bossing","longName":"3287501","preferredDefinition":"A skeletal deformity characterized by an unusually prominent forehead. Causes include acromegaly, Hurler syndrome, Silver-Russell syndrome, and thalassemia major.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Frontal Bossing","conceptCode":"C98242","definition":"A skeletal deformity characterized by an unusually prominent forehead. Causes include acromegaly, Hurler syndrome, Silver-Russell syndrome, and thalassemia major.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE180EC5-DBCE-780D-E040-BB89AD432111","latestVersionIndicator":"Yes","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DBE7-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Fractures","valueDescription":"Fracture","ValueMeaning":{"publicId":"2944828","version":"1","preferredName":"Fracture","longName":"2944828","preferredDefinition":"A traumatic injury to the bone in which the continuity of the bone is broken. - 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fracture","conceptCode":"C3046","definition":"A traumatic injury to the bone in which the continuity of the bone is broken.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74450F48-33F5-F0DB-E040-BB89AD437C48","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DBFB-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Exophthalmos","valueDescription":"Exophthalmos","ValueMeaning":{"publicId":"3286134","version":"1","preferredName":"Exophthalmos","longName":"3286134","preferredDefinition":"A protrusion of the eyeball from the socket.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exophthalmos","conceptCode":"C43262","definition":"A protrusion of the eyeball from the socket.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADF31655-2E31-2768-E040-BB89AD430D8E","latestVersionIndicator":"Yes","beginDate":"2011-09-27","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DC05-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Dentition problems","valueDescription":"Dentition Problem","ValueMeaning":{"publicId":"3286132","version":"1","preferredName":"Dentition Problem","longName":"3286132","preferredDefinition":"The teeth collectively in the dental arch. Dentition ordinarily refers to the natural teeth in position in their alveoli. Dentition referring to the deciduous teeth is DENTITION, PRIMARY; to the permanent teeth, DENTITION, PERMANENT. (From Jablonski, Dictionary of Dentistry, 1992): Problem; a state of difficulty that needs to be resolved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dentition","conceptCode":"C13072","definition":"The development and arrangement of teeth in the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Problem","conceptCode":"C28020","definition":"A difficulty, disorder, or condition needing resolution.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADF31655-2DC6-2768-E040-BB89AD430D8E","latestVersionIndicator":"Yes","beginDate":"2011-09-27","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DC0F-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Convulsions","valueDescription":"Seizure","ValueMeaning":{"publicId":"2946180","version":"1","preferredName":"Seizure","longName":"2946180","preferredDefinition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.--2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seizure","conceptCode":"C2962","definition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746BFDBA-4A04-B144-E040-BB89AD4341DF","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DC19-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Blindness / visual impairment","valueDescription":"Blindness And/Or Visual Impairment","ValueMeaning":{"publicId":"3286133","version":"1","preferredName":"Blindness And/Or Visual Impairment","longName":"3286133","preferredDefinition":"The lack of vision.  It is caused by neurological or physiological factors.: Used to indicate that either or both of two items or options: Visual; relating to or using sight; able to be seen.: Loss or abnormality of psychological, physiological, or anatomic structure or function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blindness","conceptCode":"C97109","definition":"The lack of vision. It is caused by neurological or physiological factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Visual","conceptCode":"C38059","definition":"Relating to or using sight; able to be seen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Impairment","conceptCode":"C21055","definition":"Loss or abnormality of psychological, physiological, or anatomic structure or function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADF31655-2E0C-2768-E040-BB89AD430D8E","latestVersionIndicator":"Yes","beginDate":"2011-09-27","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE180EC5-DC23-780D-E040-BB89AD432111","beginDate":"2011-09-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Urinary outlet obstruction","valueDescription":"Bladder Obstruction","ValueMeaning":{"publicId":"3309126","version":"1","preferredName":"Bladder Obstruction","longName":"3309126","preferredDefinition":"Blockage of the opening between the bladder and the urethra resulting in the reduction or prevention of the urine flow from the bladder into the urethra.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Obstruction","conceptCode":"C79541","definition":"Blockage of the opening between the bladder and the urethra resulting in the reduction or prevention of the urine flow from the bladder into the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2696424-351C-40DD-E040-BB89AD435496","latestVersionIndicator":"Yes","beginDate":"2011-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2696424-3535-40DD-E040-BB89AD435496","beginDate":"2011-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-23","modifiedBy":"ONEDATA","dateModified":"2011-11-23","deletedIndicator":"No"},{"value":"Gastric outlet obstruction","valueDescription":"Pyloric Stenosis","ValueMeaning":{"publicId":"3309127","version":"1","preferredName":"Pyloric Stenosis","longName":"3309127","preferredDefinition":"Narrowing of the pyloric lumen caused either by hypertrophy of the surrounding muscles or tissue scarring due to a chronic peptic ulcer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pyloric Stenosis","conceptCode":"C34966","definition":"Narrowing of the pyloric lumen caused either by hypertrophy of the surrounding muscles or tissue scarring due to a chronic peptic ulcer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2696424-3541-40DD-E040-BB89AD435496","latestVersionIndicator":"Yes","beginDate":"2011-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2696424-355A-40DD-E040-BB89AD435496","beginDate":"2011-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-23","modifiedBy":"ONEDATA","dateModified":"2011-11-23","deletedIndicator":"No"},{"value":"Lymphoproliferative disorder","valueDescription":"Lymphoproliferative Disorder","ValueMeaning":{"publicId":"3235573","version":"1","preferredName":"Lymphoproliferative Disorder","longName":"3235573","preferredDefinition":"A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis). --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoproliferative Disorder","conceptCode":"C9308","definition":"A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A366F43E-37D9-9973-E040-BB89AD43108C","latestVersionIndicator":"Yes","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B26E5ED4-66EF-19DB-E040-BB89AD4321E6","beginDate":"2011-05-16","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-11-23","modifiedBy":"ONEDATA","dateModified":"2011-11-23","deletedIndicator":"No"},{"value":"Thrombocytopenia","valueDescription":"Thrombocytopenia","ValueMeaning":{"publicId":"2946035","version":"1","preferredName":"Thrombocytopenia","longName":"2946035","preferredDefinition":"A condition in which there is an abnormally small number of platelets in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytopenia","conceptCode":"C3408","definition":"A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D443-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1F4ADB4-3276-11AC-E040-BB89AD436AA7","beginDate":"2011-11-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-17","modifiedBy":"ONEDATA","dateModified":"2011-11-17","deletedIndicator":"No"},{"value":"Inflammatory bowel disease","valueDescription":"Inflammatory Bowel Disease","ValueMeaning":{"publicId":"3305590","version":"1","preferredName":"Inflammatory Bowel Disease","longName":"3305590","preferredDefinition":"A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type. --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammatory Bowel Disease","conceptCode":"C3138","definition":"A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1F4ADB4-3280-11AC-E040-BB89AD436AA7","latestVersionIndicator":"Yes","beginDate":"2011-11-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1F4ADB4-3299-11AC-E040-BB89AD436AA7","beginDate":"2011-11-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-17","modifiedBy":"ONEDATA","dateModified":"2011-11-17","deletedIndicator":"No"},{"value":"Hypogammaglobulinemia","valueDescription":"Hypogammaglobulinemia","ValueMeaning":{"publicId":"3303158","version":"1","preferredName":"Hypogammaglobulinemia","longName":"3303158","preferredDefinition":"A condition in which the level of immunoglobulins (antibodies) in the blood is low and the risk of infection is high.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypogammaglobulinemia","conceptCode":"C26931","definition":"A decreased level of serum immunoglobulins. It may be inherited or acquired. It is caused by decreased or inefficient production of immunoglobulins from B cells or by a decrease in the numbers of B cells themselves. Low levels of immunoglobulins will affect the immune system's ability to combat bacterial infection. Supplementation of immunoglobulins is needed to prevent worsening outcomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1771CA1-07C7-4AE7-E040-BB89AD436974","latestVersionIndicator":"Yes","beginDate":"2011-11-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1771CA1-07E0-4AE7-E040-BB89AD436974","beginDate":"2011-11-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-11","modifiedBy":"ONEDATA","dateModified":"2011-11-11","deletedIndicator":"No"},{"value":"Hemophagocytic disorder","valueDescription":"Hemophagocytic Lymphohistiocytosis","ValueMeaning":{"publicId":"3211128","version":"1","preferredName":"Hemophagocytic Lymphohistiocytosis","longName":"3211128","preferredDefinition":"A rare but potentially life-threatening disorder characterized by the proliferation of histiocytes and macrophages and phagocytosis of red blood cells, white blood cells, and platelets. It may be inherited or secondary, due to infections, autoimmune disorders, or underlying malignancies. Signs and symptoms include fever, lymphadenopathy, hepatomegaly, splenomegaly, and pancytopenia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophagocytic Lymphohistiocytosis","conceptCode":"C34792","definition":"A rare, but potentially life-threatening disorder, characterized by the proliferation of histiocytes and macrophages, and phagocytosis of red blood cells, white blood cells, and platelets. It may be inherited or secondary due to infections, autoimmune disorders, or underlying malignancies. Signs and symptoms include fever, lymphadenopathy, hepatomegaly, splenomegaly, and pancytopenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-D1E6-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1771CA1-07F4-4AE7-E040-BB89AD436974","beginDate":"2011-11-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-11","modifiedBy":"ONEDATA","dateModified":"2011-11-11","deletedIndicator":"No"},{"value":"Mental development  delay","valueDescription":"Mental Process Development Delay","ValueMeaning":{"publicId":"3303192","version":"1","preferredName":"Mental Process Development Delay","longName":"3303192","preferredDefinition":"Conceptual functions or thinking in all its forms. (NCI): The act of improving by expanding or enlarging or refining.: Delay; time during which some action is awaited; inactivity resulting in something being put off until a later time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mental Process","conceptCode":"C16840","definition":"Any cognitive activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Development","conceptCode":"C84377","definition":"The act of improving by expanding or enlarging or refining.","evsSource":"RADLEX_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Delay","conceptCode":"C25476","definition":"Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B17DAFFD-B97A-EDCF-E040-BB89AD4361B9","latestVersionIndicator":"Yes","beginDate":"2011-11-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-11-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B17DAFFD-B993-EDCF-E040-BB89AD4361B9","beginDate":"2011-11-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-11-11","modifiedBy":"ONEDATA","dateModified":"2011-11-11","deletedIndicator":"No"},{"value":"Neutropenia","valueDescription":"Neutrophil Count Decreased","ValueMeaning":{"publicId":"2945772","version":"1","preferredName":"Neutrophil Count Decreased","longName":"2945772","preferredDefinition":"A decrease in the number of neutrophils in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neutropenia","conceptCode":"C80520","definition":"A decrease in the number of neutrophils in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7458E815-911C-DD76-E040-BB89AD43104A","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF6C4760-6B2A-DEB3-E040-BB89AD434AC4","beginDate":"2012-11-26","endDate":null,"createdBy":"KNUTSOND","dateCreated":"2012-11-26","modifiedBy":"ONEDATA","dateModified":"2012-11-26","deletedIndicator":"No"},{"value":"Fever","valueDescription":"Fever","ValueMeaning":{"publicId":"3123435","version":"1","preferredName":"Fever","longName":"3123435","preferredDefinition":"A disorder characterized by elevation of the body's temperature above the upper limit of normal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fever","conceptCode":"E11102","definition":"A disorder characterized by elevation of the body's temperature above the upper limit of normal.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBEC77A-A059-3404-E040-BB89AD43456A","latestVersionIndicator":"Yes","beginDate":"2010-07-19","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-07-19","modifiedBy":"ONEDATA","dateModified":"2010-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF6C4760-6B36-DEB3-E040-BB89AD434AC4","beginDate":"2012-11-26","endDate":null,"createdBy":"KNUTSOND","dateCreated":"2012-11-26","modifiedBy":"ONEDATA","dateModified":"2012-11-26","deletedIndicator":"No"},{"value":"Anemia","valueDescription":"Anemia","ValueMeaning":{"publicId":"2568585","version":"1","preferredName":"Anemia","longName":"2568585","preferredDefinition":"A reduction in the number of red blood cells per cu mm, the amount of hemoglobin in 100 ml of blood, and the volume of packed red blood cells per 100 ml of blood. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anemia","conceptCode":"C2869","definition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D8F6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-25","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF6C4760-6B40-DEB3-E040-BB89AD434AC4","beginDate":"2012-11-26","endDate":null,"createdBy":"KNUTSOND","dateCreated":"2012-11-26","modifiedBy":"ONEDATA","dateModified":"2012-11-26","deletedIndicator":"No"},{"value":"Graft versus host disease due to maternal engraftment","valueDescription":"Graft Versus Host Disease Reason Maternal Engraftment","ValueMeaning":{"publicId":"3640457","version":"1","preferredName":"Graft Versus Host Disease Reason Maternal Engraftment","longName":"3640457","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.: An explanation of the cause of some phenomenon or action.: A designation that has some relationship to motherhood.: The establishment of viable, functional grafted tissue within the body of a host.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Maternal","conceptCode":"C89336","definition":"A designation that has some relationship to motherhood.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Engraftment","conceptCode":"C37947","definition":"The establishment of viable, functional grafted tissue within the body of a host.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D093EA71-1F87-7385-E040-BB89AD433A4B","latestVersionIndicator":"Yes","beginDate":"2012-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D093EA71-1FA0-7385-E040-BB89AD433A4B","beginDate":"2012-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-11","modifiedBy":"ONEDATA","dateModified":"2012-12-11","deletedIndicator":"No"},{"value":"Hepatosplenomegaly","valueDescription":"Hepatosplenomegaly","ValueMeaning":{"publicId":"3637923","version":"1","preferredName":"Hepatosplenomegaly","longName":"3637923","preferredDefinition":"An abnormal enlargement of both the liver and spleen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatosplenomegaly","conceptCode":"C97345","definition":"An abnormal enlargement of both the liver and spleen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0209A7E-B8BF-D19B-E040-BB89AD432DDA","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D0209A7E-B8D8-D19B-E040-BB89AD432DDA","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Maternal T-cell engraftment","valueDescription":"Maternal T-Lymphocyte Engraftment","ValueMeaning":{"publicId":"3637924","version":"1","preferredName":"Maternal T-Lymphocyte Engraftment","longName":"3637924","preferredDefinition":"A designation that has some relationship to motherhood.: One type of white blood cell that attacks virus-infected cells, foreign cells, and cancer cells.  T cells also produce a number of substances that regulate the immune response.: The establishment of viable, functional grafted tissue within the body of a host.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maternal","conceptCode":"C89336","definition":"A designation that has some relationship to motherhood.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T-Lymphocyte","conceptCode":"C12476","definition":"A thymocyte-derived lymphocyte of immunological importance that is long-lived (months to years) and is responsible for cell-mediated immunity. T lymphocyte cells form rosettes with sheep erythrocytes and, in the presence of transforming agents (mitogens), differentiate and divide. These cells have the characteristic T3 surface marker and may be further divided into subsets according to function, such as helper, cytotoxic, etc.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Engraftment","conceptCode":"C37947","definition":"The establishment of viable, functional grafted tissue within the body of a host.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0209A7E-B8E6-D19B-E040-BB89AD432DDA","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D0209A7E-B901-D19B-E040-BB89AD432DDA","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Microcephaly","valueDescription":"Microcephaly","ValueMeaning":{"publicId":"3004991","version":"1","preferredName":"Microcephaly","longName":"3004991","preferredDefinition":"A congenital or acquired developmental disorder in which the circumference of the head is smaller than normal for the person's age and sex.  It is the result of brain developmental delay.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microcephaly","conceptCode":"C85874","definition":"A congenital or acquired developmental disorder in which the circumference of the head is smaller than normal for the person's age and sex.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E550547-1A6F-00B1-E040-BB89AD435E51","latestVersionIndicator":"Yes","beginDate":"2010-01-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-01-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D0209A7E-B90D-D19B-E040-BB89AD432DDA","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Skin rash","valueDescription":"Skin Rash","ValueMeaning":{"publicId":"2578055","version":"1","preferredName":"Skin Rash","longName":"2578055","preferredDefinition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Rash","conceptCode":"C39594","definition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDF4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"COOPERM","dateModified":"2017-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D0209A7E-B917-D19B-E040-BB89AD432DDA","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Hypoproteinemia","valueDescription":"Hypoproteinemia","ValueMeaning":{"publicId":"3637925","version":"1","preferredName":"Hypoproteinemia","longName":"3637925","preferredDefinition":"A laboratory test result indicating abnormally low levels of total protein in the serum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypoproteinemia","conceptCode":"C88511","definition":"A laboratory test result indicating abnormally low levels of total protein in the serum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0209A7E-B923-D19B-E040-BB89AD432DDA","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D0209A7E-B93C-D19B-E040-BB89AD432DDA","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Graft versus host disease due to blood transfusion","valueDescription":"Graft Versus Host Disease Reason Blood Transfusion","ValueMeaning":{"publicId":"3637927","version":"1","preferredName":"Graft Versus Host Disease Reason Blood Transfusion","longName":"3637927","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.: An explanation of the cause of some phenomenon or action.: The administration of blood or blood products into a blood vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Blood Transfusion","conceptCode":"C15192","definition":"The injection of whole blood or a blood component directly into the bloodstream.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0209A7E-B957-D19B-E040-BB89AD432DDA","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D0209A7E-B972-D19B-E040-BB89AD432DDA","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Eosinophilia","valueDescription":"Eosinophilia","ValueMeaning":{"publicId":"2793850","version":"1","preferredName":"Eosinophilia","longName":"2793850","preferredDefinition":"A condition in which the number of eosinophils (a type of white blood cell) in the blood is greatly increased. Eosinophilia is often a response to infection or allergens (substances that cause an allergic response).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eosinophilia","conceptCode":"C3015","definition":"Abnormal high level of eosinophils in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"594ACCA7-61B4-720E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-15","modifiedBy":"KUMMEROA","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D0209A7E-B97C-D19B-E040-BB89AD432DDA","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Edema","valueDescription":"Edema","ValueMeaning":{"publicId":"3637928","version":"1","preferredName":"Edema","longName":"3637928","preferredDefinition":"Accumulation of an excessive amount of watery fluid in cells or intercellular tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Edema","conceptCode":"C3002","definition":"Accumulation of an excessive amount of fluid in cells or intercellular tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0209A7E-B986-D19B-E040-BB89AD432DDA","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D0209A7E-B99F-D19B-E040-BB89AD432DDA","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Bone abnormalities","valueDescription":"Bone Abnormality","ValueMeaning":{"publicId":"3637929","version":"1","preferredName":"Bone Abnormality","longName":"3637929","preferredDefinition":"Connective tissue that forms the skeletal components of the body.: A condition that differs from the usual physical or mental state.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone","conceptCode":"C12366","definition":"The structural organ comprised of specialized connective tissue that forms the skeletal components of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0209A7E-B9AC-D19B-E040-BB89AD432DDA","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D0209A7E-B9C5-D19B-E040-BB89AD432DDA","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Other disease","valueDescription":"Other Disease or Disorder","ValueMeaning":{"publicId":"3158622","version":"1","preferredName":"Other Disease or Disorder","longName":"3158622","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94B8AE1D-5BF8-C169-E040-BB89AD435EB4","latestVersionIndicator":"Yes","beginDate":"2010-11-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E57B8AAF-B1B9-17AA-E040-BB89AD436826","beginDate":"2013-09-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-09-03","modifiedBy":"ONEDATA","dateModified":"2013-09-03","deletedIndicator":"No"},{"value":"Thalassemia","valueDescription":"Thalassemia","ValueMeaning":{"publicId":"2593293","version":"1","preferredName":"Thalassemia","longName":"2593293","preferredDefinition":"A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thalassemia","conceptCode":"C35069","definition":"An inherited blood disorder characterized by a decreased synthesis of one of the polypeptide chains that form hemoglobin. Anemia results from this abnormal hemoglobin formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28821A33-CC97-19A3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E57B8AAF-B1C3-17AA-E040-BB89AD436826","beginDate":"2013-09-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-09-03","modifiedBy":"ONEDATA","dateModified":"2013-09-03","deletedIndicator":"No"},{"value":"Sickle cell anemia","valueDescription":"Sickle Cell Disease","ValueMeaning":{"publicId":"3301976","version":"1","preferredName":"Sickle Cell Disease","longName":"3301976","preferredDefinition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Cell Disease","conceptCode":"C34383","definition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B128A231-DFDE-22B8-E040-BB89AD436DCB","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E57B8AAF-B1D7-17AA-E040-BB89AD436826","beginDate":"2013-09-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-09-03","modifiedBy":"ONEDATA","dateModified":"2013-09-03","deletedIndicator":"No"},{"value":"Giant leukocyte granules","valueDescription":"Large Granulocyte","ValueMeaning":{"publicId":"4293936","version":"1","preferredName":"Large Granulocyte","longName":"4293936","preferredDefinition":"Of considerable or relatively great size, extent, or capacity.: A leucocyte with conspicuous cytoplasmic granules. In humans the granulocytes are also classified as polymorphonuclear leucocytes and are subdivided according to the staining properties of the granules into eosinophils, basophils and neutrophils.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large","conceptCode":"C49508","definition":"Of considerable or relatively great size, extent, or capacity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Granulocyte","conceptCode":"C12530","definition":"A type of leukocyte with a multilobed nucleus and cytoplasmic granules. The unique morphology of the nucleus has led to their also being known as polymorphonuclear leukocytes (PMLs or PMNs). Granulocytes are subdivided according to the staining properties of their granules into eosinophils (red with acidic dye), basophils (blue with basic dye), and neutrophils (not amenable to staining with either acidic or basic dyes).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8D473D5-40A1-380F-E040-BB89AD43084E","latestVersionIndicator":"Yes","beginDate":"2014-05-07","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8D473D5-40BA-380F-E040-BB89AD43084E","beginDate":"2014-05-07","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-07","modifiedBy":"ONEDATA","dateModified":"2014-05-07","deletedIndicator":"No"},{"value":"Facial dysmorphisms","valueDescription":"Abnormality Face","ValueMeaning":{"publicId":"4293937","version":"1","preferredName":"Abnormality Face","longName":"4293937","preferredDefinition":"A condition that differs from the usual physical or mental state.: The anterior portion of the head extending from the forehead to the chin and ear to ear. The facial structures contain the eyes, nose and mouth, cheeks and jaws.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Face","conceptCode":"C13071","definition":"The anterior portion of the head extending from the forehead to the chin and ear to ear. The facial structures contain the eyes, nose and mouth, cheeks and jaws.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8D473D5-40C7-380F-E040-BB89AD43084E","latestVersionIndicator":"Yes","beginDate":"2014-05-07","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8D473D5-40E0-380F-E040-BB89AD43084E","beginDate":"2014-05-07","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-07","modifiedBy":"ONEDATA","dateModified":"2014-05-07","deletedIndicator":"No"},{"value":"Ocular albinism","valueDescription":"Ocular Albinism","ValueMeaning":{"publicId":"4293938","version":"1","preferredName":"Ocular Albinism","longName":"4293938","preferredDefinition":"Of or relating to the eye.: A congenital disorder characterized by partial or complete absence of melanin pigment in the eyes, hair and skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ocular","conceptCode":"C87163","definition":"Of or relating to the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Albinism","conceptCode":"C84543","definition":"A congenital disorder characterized by partial or complete absence of melanin pigment in the eyes, hair and skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8D473D5-40ED-380F-E040-BB89AD43084E","latestVersionIndicator":"Yes","beginDate":"2014-05-07","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8D473D5-4106-380F-E040-BB89AD43084E","beginDate":"2014-05-07","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-07","modifiedBy":"ONEDATA","dateModified":"2014-05-07","deletedIndicator":"No"},{"value":"Recurrent infections","valueDescription":"Recurrent Infectious Disorder","ValueMeaning":{"publicId":"4295701","version":"1","preferredName":"Recurrent Infectious Disorder","longName":"4295701","preferredDefinition":"occurring again.: A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent","conceptCode":"C14173","definition":"Occurring again.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8F9B2BA-273E-6FDE-E040-BB89AD437814","latestVersionIndicator":"Yes","beginDate":"2014-05-09","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8F9B2BA-2757-6FDE-E040-BB89AD437814","beginDate":"2014-05-09","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-09","modifiedBy":"ONEDATA","dateModified":"2014-05-09","deletedIndicator":"No"},{"value":"Skin involvement","valueDescription":"Skin Involvement","ValueMeaning":{"publicId":"4240358","version":"1","preferredName":"Skin Involvement","longName":"4240358","preferredDefinition":"An organ that constitutes the external surface of the body.  It consists of the epidermis, dermis, and skin appendages.: To have a connection by participation or association or use; sharing in an activity or process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F50B585A-72E1-12AB-E040-BB89AD437110","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50B585A-72FA-12AB-E040-BB89AD437110","beginDate":"2014-03-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Neurofibromatosis","valueDescription":"Neurofibromatosis","ValueMeaning":{"publicId":"2967364","version":"1","preferredName":"Neurofibromatosis","longName":"2967364","preferredDefinition":"A group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. NEUROFIBROMATOSIS 1 (generalized neurofibromatosis) accounts for approximately 95% of cases, although multiple additional subtypes (e.g., NEUROFIBROMATOSIS 2, neurofibromatosis 3, etc.) have been described. (From Neurochirurgie 1998 Nov;44(4):267-72)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurofibromatosis","conceptCode":"C6727","definition":"An autosomal dominant hereditary neoplastic syndrome. Two distinct clinicopathological entities are recognized: neurofibromatosis type 1 and neurofibromatosis type 2. Neurofibromatosis type 1 is associated with the presence of cafe-au-lait cutaneous lesions, multiple neurofibromas, malignant peripheral nerve sheath tumors, optic nerve gliomas, and bone lesions. Neurofibromatosis type 2 is associated with the presence of schwannomas, meningiomas, and gliomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AB32307-5790-1A4F-E040-BB89AD43618C","latestVersionIndicator":"Yes","beginDate":"2009-12-14","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50B585A-7304-12AB-E040-BB89AD437110","beginDate":"2014-03-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Adenopathy","valueDescription":"Lymphadenopathy","ValueMeaning":{"publicId":"4240359","version":"1","preferredName":"Lymphadenopathy","longName":"4240359","preferredDefinition":"A clinical finding indicating that a lymph node is enlarged. Causes include viral and bacterial infections and cancers that affect the lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphadenopathy","conceptCode":"C50764","definition":"An enlarged lymph node. Causes include viral and bacterial infections and cancers that affect the lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F50B585A-730E-12AB-E040-BB89AD437110","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F50B585A-7327-12AB-E040-BB89AD437110","beginDate":"2014-03-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-03-20","modifiedBy":"ONEDATA","dateModified":"2014-03-20","deletedIndicator":"No"},{"value":"Fair hair and/or abnormal accumulation of pigment at microscopic examination of hair","valueDescription":"Microscopic Examination Hair Abnormal Pigment Collection And/Or Fair Hair","ValueMeaning":{"publicId":"4295557","version":"1","preferredName":"Microscopic Examination Hair Abnormal Pigment Collection And/Or Fair Hair","longName":"4295557","preferredDefinition":"An assessment by microscope.: The filamentous outgrowth of the epidermis.: Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.: A substance that gives color to tissue. Pigments are responsible for the color of skin, eyes, and hair.: The act of gathering things together; having been brought together in one place.: Used to indicate that either or both of two items or options may be valid.: A human hair color characterized by low levels of eumelanin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microscopic Examination","conceptCode":"C90424","definition":"An assessment by microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Hair","conceptCode":"C32705","definition":"The filamentous outgrowth of the epidermis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Pigment","conceptCode":"C747","definition":"A substance that gives color to tissue. Pigments are responsible for the color of skin, eyes, and hair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Collection","conceptCode":"C25453","definition":"The act of gathering things together; having been brought together in one place.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fair Hair","conceptCode":"C115219","definition":"A human hair color characterized by low levels of eumelanin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8F84D3E-76D6-1745-E040-BB89AD43782D","latestVersionIndicator":"Yes","beginDate":"2014-05-09","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8F84D3E-76EF-1745-E040-BB89AD43782D","beginDate":"2014-05-09","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-09","modifiedBy":"ONEDATA","dateModified":"2014-05-09","deletedIndicator":"No"},{"value":"Skin albinism / fair skin","valueDescription":"Skin Hypopigmentation Or Fair Skin","ValueMeaning":{"publicId":"4295558","version":"1","preferredName":"Skin Hypopigmentation Or Fair Skin","longName":"4295558","preferredDefinition":"Abnormal lightening of skin due to decreased melanin production or deposition. Vitiligo, albinism, and leukoderma are among the disorders that are associated with skin hypopigmentation.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A human skin color characterized by low levels of eumelanin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Hypopigmentation","conceptCode":"C78610","definition":"Abnormal lightening of skin due to decreased melanin production or deposition. Vitiligo, albinism, and leukoderma are among the disorders that are associated with skin hypopigmentation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fair Skin","conceptCode":"C115220","definition":"A human skin color characterized by low levels of eumelanin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8F84D3E-76FD-1745-E040-BB89AD43782D","latestVersionIndicator":"Yes","beginDate":"2014-05-09","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8F84D3E-7716-1745-E040-BB89AD43782D","beginDate":"2014-05-09","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-09","modifiedBy":"ONEDATA","dateModified":"2014-05-09","deletedIndicator":"No"},{"value":"Bleeding diathesis","valueDescription":"Bleeding Diathesis","ValueMeaning":{"publicId":"4295559","version":"1","preferredName":"Bleeding Diathesis","longName":"4295559","preferredDefinition":"A coagulation disorder characterized by a tendency for excessive bleeding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bleeding Diathesis","conceptCode":"C115221","definition":"A coagulation disorder characterized by a tendency for excessive bleeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8F84D3E-7722-1745-E040-BB89AD43782D","latestVersionIndicator":"Yes","beginDate":"2014-05-09","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8F84D3E-773B-1745-E040-BB89AD43782D","beginDate":"2014-05-09","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-09","modifiedBy":"ONEDATA","dateModified":"2014-05-09","deletedIndicator":"No"},{"value":"Hemoglobinopathy","valueDescription":"Hemoglobinopathy","ValueMeaning":{"publicId":"2593295","version":"1","preferredName":"Hemoglobinopathy","longName":"2593295","preferredDefinition":"A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobinopathy","conceptCode":"C3092","definition":"An inherited disorder characterized by structural alterations of a globin chain within the hemoglobin molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28821A9F-371A-19B1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"72C7E458-B7E8-1F12-E053-F662850A6C04","beginDate":"2018-08-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-06","modifiedBy":"ONEDATA","dateModified":"2018-08-06","deletedIndicator":"No"},{"value":"G6PD","valueDescription":"Glucose-6-Phosphate Dehydrogenase Deficiency","ValueMeaning":{"publicId":"5944606","version":"1","preferredName":"Glucose-6-Phosphate Dehydrogenase Deficiency","longName":"5944606","preferredDefinition":"An X-linked recessive inherited disorder caused by mutations in the G6PD gene. It is characterized by the absence or presence of very low levels of glucose-6-phosphate dehydrogenase. Patients develop hemolytic anemia usually in response to infection or exposure to drugs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glucose-6-Phosphate Dehydrogenase Deficiency","conceptCode":"C98933","definition":"An X-linked recessive inherited disorder caused by mutations in the G6PD gene. It is characterized by the absence or presence of very low levels of glucose-6-phosphate dehydrogenase. Patients develop hemolytic anemia usually in response to infection or exposure to drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57E9DF54-BE0A-7A61-E053-F662850A15E0","latestVersionIndicator":"Yes","beginDate":"2017-08-29","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-08-29","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"72C7E458-B7FC-1F12-E053-F662850A6C04","beginDate":"2018-08-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-06","modifiedBy":"ONEDATA","dateModified":"2018-08-06","deletedIndicator":"No"},{"value":"Other hemoglobinopathy","valueDescription":"Other Hemoglobinopathy","ValueMeaning":{"publicId":"2689130","version":"1","preferredName":"Other Hemoglobinopathy","longName":"2689130","preferredDefinition":"Different than the one(s) previously specified or mentioned.: An inherited disorder characterized by structural alterations of a globin chain within the hemoglobin molecule.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hemoglobinopathy","conceptCode":"C3092","definition":"An inherited disorder characterized by structural alterations of a globin chain within the hemoglobin molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4CD380-7D91-58CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"KUMMEROA","dateModified":"2020-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"83E9777B-E839-41EE-E053-F662850AE748","beginDate":"2019-03-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2230030","version":"1","preferredName":"Finding Type","preferredDefinition":"Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.:Type; a subdivision of a particular kind of thing.","longName":"C3367:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6EF4E2B-7A55-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-17","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-17","modifiedBy":"ONEDATA","dateModified":"2005-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7350EF78-48AF-5D1F-E040-BB89AD431E2E","latestVersionIndicator":"Yes","beginDate":"2009-09-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-09-11","modifiedBy":"KUMMEROA","dateModified":"2019-03-12","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"3638517","version":"1","longName":"2031r2: Immune Deficiencies Pre-HSCT Data","context":"NHLBI"},{"publicId":"3279241","version":"1","longName":"2034r1: X-Linked Lymphoproliferative Syndrome Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964931","version":"1","longName":"2014r1: MDS Pre-HSCT Data","context":"NHLBI"},{"publicId":"3279261","version":"1","longName":"2136r1: Osteopetrosis Post-HSCT Data","context":"NHLBI"},{"publicId":"3279243","version":"1","longName":"2036r1: Osteopetrosis Pre-HSCT Data","context":"NHLBI"},{"publicId":"3234637","version":"1","longName":"2131r2: Immune Deficiencies Post-HSCT Data","context":"NHLBI"},{"publicId":"3279260","version":"1","longName":"2134r1: X-Linked Lymphoproliferative Syndrome Post-HSCT Data","context":"NHLBI"},{"publicId":"3279271","version":"1","longName":"Disease Status","context":"NHLBI"},{"publicId":"3279262","version":"1","longName":"2139r1: Hemophagocytic Lymphohistiocytosis Post-HSCT Data","context":"NHLBI"},{"publicId":"3279244","version":"1","longName":"2039r1: Hemophagocytic Lymphohistiocytosis Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedMedicalConditionResult:value ","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What finding is present?","type":"Preferred Question Text","description":"What finding is present?","url":null,"context":"NHLBI"},{"name":"What kind of clinical features were presented?","type":"Alternate Question Text","description":"What kind of clinical features were presented?","url":null,"context":"NHLBI"},{"name":"Specify the presence of the following clinical indicators","type":"Alternate Question Text","description":"Specify the presence of the following clinical indicators","url":null,"context":"NHLBI"},{"name":"Specify the recipient's clinical status:","type":"Alternate Question Text","description":"Specify the recipient's clinical status:","url":null,"context":"NHLBI"},{"name":"Specify if the recipient displayed evidence of the following disorders:","type":"Alternate Question Text","description":"Specify if the recipient displayed evidence of the following disorders:","url":null,"context":"NHLBI"},{"name":"Did the recipient experience any of the following clinical features?","type":"Alternate Question Text","description":"Did the recipient experience any of the following clinical features?","url":null,"context":"NHLBI"},{"name":"What features were present?","type":"Alternate Question Text","description":"What features were present?","url":null,"context":"NHLBI"},{"name":"What was the clinical finding?","type":"Alternate Question Text","description":"What was the clinical finding?","url":null,"context":"NHLBI"},{"name":"Was there evidence of the following clinical features?","type":"Alternate Question Text","description":"Was there evidence of the following clinical features?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2950100","type":"BRIDG Mapping Path","description":"\"PerformedDiagnosis [primary] > PerformedObservation [diagnosis] > AssessedResultRelationship > PerformedMedicalConditionResult.value [sign] WHERE  PerformedDiagnosis.value = \"\"Myelodysplasia / Myeloproliferative Disorders\"\"\"","url":null,"context":"NHLBI"},{"name":"Specify whether the recipient expressed the following clinical features:","type":"Alternate Question Text","description":"Specify whether the recipient expressed the following clinical features:","url":null,"context":"NHLBI"},{"name":"Specify whether the recipient expressed the following clinical features at diagnosis","type":"Application Standard Question Text","description":"Specify whether the recipient expressed the following clinical features at diagnosis","url":null,"context":"NHLBI"},{"name":"Specify the following clinical and laboratory features","type":"Alternate Question Text","description":"Specify the following clinical and laboratory features","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"74F9436A-E8C9-B5D6-E040-BB89AD430EB8","latestVersionIndicator":"Yes","beginDate":"2009-10-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-10-02","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":". System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}